Sana Biotechnology (SANA), a clinical-stage biotech company specializing in gene and cell therapies, has recently experienced significant moves in its stock performance, attracting investor attention.

Yet Sana’s stock price initially soared 200%. And even if experts weren’t quite as exuberant, some acknowledged the company and the field had potentially taken an important step forward.

If you are looking for an AI stock that is more promising than SANA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 10 Hottest Mid ...

Sana Biotechnology (SANA) stock soared after the company announced what it believes is a world-first breakthrough for type-1 diabetes treatments. Shares of SANA were up about 400% at one stage ...

Sana’s HIP technology aims to eliminate the ... In three months, CytomX Therapeutics’ stock has lost 14.5%. CTMX’s earnings beat estimates in two of the trailing four quarters and missed ...

Shares of Sana Biotechnology SANA skyrocketed 151.5% in the past week after the company announced positive initial results from a potentially groundbreaking type 1 diabetes (T1D) study of its ...